September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of factors affecting the tear-film lipid layer thickness
Author Affiliations & Notes
  • Tae-im Kim
    Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea (the Republic of)
  • Si Yoon Park
    Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea (the Republic of)
  • Ji Won Jung
    Department of Ophthalmology, Inha University School of Medicine, Incheon, Korea (the Republic of)
  • Kyoung Yul Seo
    Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea (the Republic of)
  • Hun Lee
    Department of Ophthalmology, International St. Mary's Hospital,Catholic Kwandong University College of Medicine, Incheon, Korea (the Republic of)
  • Yong woo Ji
    Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea (the Republic of)
  • Eung Kweon Kim
    Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Tae-im Kim, None; Si Yoon Park, None; Ji Won Jung, None; Kyoung Yul Seo, None; Hun Lee, None; Yong woo Ji, None; Eung Kweon Kim, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5674. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tae-im Kim, Si Yoon Park, Ji Won Jung, Kyoung Yul Seo, Hun Lee, Yong woo Ji, Eung Kweon Kim; Evaluation of factors affecting the tear-film lipid layer thickness. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5674.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the effects of age, sex, history of ocular surgery and contact lens use, and ocular surface and meibomian gland parameters on the lipid layer thickness (LLT) in normal subjects and patients with dry eye syndrome.

Methods : Cross-sectional, observational case series.
Patients with dry eye syndrome and subjects with a healthy ocular surface were enrolled. All participants underwent LLT measurement with a LipiView interferometer, tear meniscus height measurement using optical coherence tomography, tear film break-up time (TBUT) determination, corneal and conjunctival staining, Schirmer's test, examination of the lid margins and meibomian glands, and assessment using the Ocular Surface Disease Index (OSDI) questionnaire. Univariate and multivariate linear regression analyses were performed to assess the impact of clinical variables, including age, sex, history of refractive surgery, cataract surgery, contact lens use, and ocular surface and meibomian gland parameters, on the LLT in normal subjects and patients with dry eye syndrome.

Results : A total of 96 eyes of 96 normal subjects and 326 eyes of 326 patients with dry eye syndrome were enrolled.In normal subjects, the median (range) LLT was 65 (33-100), and age (β = 0.691, P = 0.042) was the only factor that was significantly associated with the LLT. In patients with dry eye syndrome, 79.14% of the participants fulfilled the diagnostic criteria for meibomian gland dysfunction (MGD). MGD was classified as obstructive (79.07%) or hypersecretory (20.93%), and the median (range) LLT was 84 (20-100) interferometric color units (ICU). In a multivariate analysis, increased age and female sex were significantly related to increased LLT (β =0.298, P = 0.001 for age and β = 11.330, P ≤ 0.001 for female sex), and hypersecretory MGD and lid margin inflammation were independently associated with increased LLT (β = 11.296, P = 0.001 and β = 9.808, P =0.004, respectively).

Conclusions : LLT measurements using a new interferometer are significantly affected by demographic factors such as age, sex, ocular surgical history, and MGD type. Therefore, all of these factors must be considered in the diagnosis of ocular surface diseases, including dry eye syndrome.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×